Dr. Richard Furman InterviewASH 2012

[bkoffman]

Hi friends

I just posted the second part of my ASH 2012 interview with Dr. Furman on his experience with ibrutinib and idelasilib (GS-1101), what is known, what isn't, and what the future might hold.

He outlines an interesting CLL survival strategy based on the pipeline of new drugs

See bkoffman.blogspot.com

Stay strong

We are all in this together

Brian

[jangreen]

Thanks for these videos. They are important in the understanding of treatments for CLL